A corollary to this hypothesis is that medications commonly used to treat hyperglycemia and hypertriglyceridemia should fail to function in RLIP76−/− mice if RLIP76 is indeed necessary for the clinical manifestations of oxidative-stress characteristic of MSy and T2D. This evidence concerns the gene RALBP1 and type 2 diabetes mellitus.